New Atmosphere, New Vision: Gibson and Whittemore Kick Off Invest in ME Conference 2016
Mark Berry reports on Dr. Gibson's introduction and Dr. Whittemore's keynote speech, at the 11th Invest in ME International ME Conference in London.
Discuss the article on the Forums.

CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update etc.

Discussion in 'Other Health News and Research' started by Dolphin, Aug 26, 2017.

  1. Dolphin

    Dolphin Senior Member

    Messages:
    10,557
    Likes:
    27,561
    These are the guidelines about how you should report randomised controlled trials.

    Most of us here won't be reporting on our own trials but it can be interesting to read how trials should be reported and hence how trials shouldn't be reported.


    Free full text: http://annals.org/aim/article/26332...ogic-treatments-2017-update-consort-extension

     
    barbc56, Effi, Valentijn and 9 others like this.
  2. Dolphin

    Dolphin Senior Member

    Messages:
    10,557
    Likes:
    27,561
    Adherence has not been discussed in some ME/CFS trials. I think it may have improved in recent years, though it is often simply how many appointments a participant attended. Sometimes therapists are asked to rate the adherence of participants to the intervention. But detailed examination and reporting of exercise logs for example doesn't usually if ever get mentioned.
     
    Last edited: Aug 27, 2017
  3. Dolphin

    Dolphin Senior Member

    Messages:
    10,557
    Likes:
    27,561
    A lack of blinding in a lot of ME/CFS trials rarely gets mentioned. Also blinded assessors are rarely used as I recall.
     
  4. Dolphin

    Dolphin Senior Member

    Messages:
    10,557
    Likes:
    27,561
    I'm not sure I was previously aware of this TIDieR checklist.
     
    Valentijn, Esther12 and barbc56 like this.
  5. Dolphin

    Dolphin Senior Member

    Messages:
    10,557
    Likes:
    27,561
    I would also add that just because a paper adheres well to the CONSORT guidelines, doesn't mean that the results of the trial itself are necessarily very strong. For example an nonblinded trial based solely on subjective outcome measures could adhere well to CONSORT guidelines.
     
  6. Dolphin

    Dolphin Senior Member

    Messages:
    10,557
    Likes:
    27,561
     
    Valentijn, Esther12 and barbc56 like this.
  7. Dolphin

    Dolphin Senior Member

    Messages:
    10,557
    Likes:
    27,561
    I'm not sure how much this point relates to CONSORT but it is interesting to hear talk of "patient preferences". This is something that tends to be neglected in systems offering CBT and GET for ME/CFS. Discussing "patient preferences" might be a way to challenge the offering of CBT and GET and basically nothing else.
     
    Valentijn, Esther12 and barbc56 like this.
  8. Dolphin

    Dolphin Senior Member

    Messages:
    10,557
    Likes:
    27,561
    Nothing particularly amazingly new here but I find it interesting to hear examples of how blinding is dealt with

     
    Valentijn, Esther12 and barbc56 like this.
  9. Dolphin

    Dolphin Senior Member

    Messages:
    10,557
    Likes:
    27,561
    I find it interesting to see these issues discussed.
     
    Esther12 likes this.

See more popular forum discussions.

Share This Page